Since OXPHOS and FAO have been recently reported as upregulated under prolonged anti-estrogen therapy and critical to anti-estrogen-resistant BC persistence, we performed Seahorse FAO assays to assess whether AR promotes ER-mutant BC OXPHOS and FAO under AI therapy-mimicking conditions. The gene discussed is AR; the disease is breast cancer.